NasdaqCM - Delayed Quote USD

BIOLASE, Inc. (BIOL)

0.1511 +0.0011 (+0.73%)
At close: 4:00 PM EDT
0.1520 +0.00 (+0.60%)
After hours: 4:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
49,164.0000
49,164.0000
48,462.0000
39,188.0000
22,780.0000
Cost of Revenue
32,440.0000
32,440.0000
32,551.0000
22,659.0000
16,607.0000
Gross Profit
16,724.0000
16,724.0000
15,911.0000
16,529.0000
6,173.0000
Operating Expense
34,661.0000
34,661.0000
41,249.0000
32,645.0000
24,709.0000
Operating Income
-17,937.0000
-17,937.0000
-25,338.0000
-16,116.0000
-18,536.0000
Net Non Operating Interest Income Expense
-2,361.0000
-2,361.0000
-2,749.0000
-2,224.0000
-2,359.0000
Other Income Expense
-303.0000
-303.0000
-438.0000
2,247.0000
4,194.0000
Pretax Income
-20,601.0000
-20,601.0000
-28,525.0000
-16,093.0000
-16,701.0000
Tax Provision
31.0000
31.0000
109.0000
65.0000
128.0000
Net Income Common Stockholders
-37,619.0000
-37,619.0000
-28,851.0000
-16,704.0000
-34,207.0000
Diluted NI Available to Com Stockholders
-37,619.0000
-37,619.0000
-28,851.0000
-16,704.0000
-34,207.0000
Basic EPS
-29.44
-29.44
-418.13
-283.12
-1.40k
Diluted EPS
-29.44
-29.44
-418.13
-283.12
-1.40k
Basic Average Shares
1,278.0000
1,278.0000
69.0000
59.0000
24.4500
Diluted Average Shares
1,278.0000
1,278.0000
69.0000
59.0000
24.4500
Total Operating Income as Reported
-17,937.0000
-17,937.0000
-25,338.0000
-16,431.0000
-18,536.0000
Total Expenses
67,101.0000
67,101.0000
73,800.0000
55,304.0000
41,316.0000
Net Income from Continuing & Discontinued Operation
-20,632.0000
-20,632.0000
-28,634.0000
-16,158.0000
-16,829.0000
Normalized Income
-20,281.3510
-20,281.3510
-28,197.3140
-18,396.0120
-16,813.6700
Interest Expense
2,361.0000
2,361.0000
2,749.0000
2,224.0000
2,359.0000
Net Interest Income
-2,361.0000
-2,361.0000
-2,749.0000
-2,224.0000
-2,359.0000
EBIT
-18,240.0000
-18,240.0000
-25,776.0000
-13,869.0000
-14,342.0000
EBITDA
-15,442.0000
-15,442.0000
-25,279.0000
-13,469.0000
-13,843.0000
Reconciled Cost of Revenue
32,440.0000
32,440.0000
32,551.0000
22,659.0000
16,607.0000
Reconciled Depreciation
2,798.0000
2,798.0000
497.0000
400.0000
499.0000
Net Income from Continuing Operation Net Minority Interest
-20,632.0000
-20,632.0000
-28,634.0000
-16,158.0000
-16,829.0000
Total Unusual Items Excluding Goodwill
-351.0000
-351.0000
-438.0000
2,247.0000
-21.0000
Total Unusual Items
-351.0000
-351.0000
-438.0000
2,247.0000
-21.0000
Normalized EBITDA
-15,091.0000
-15,091.0000
-24,841.0000
-15,716.0000
-13,822.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0003
Tax Effect of Unusual Items
-0.3510
-0.3510
-1.3140
8.9880
-5.6700
12/31/2020 - 11/12/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SINT Sintx Technologies, Inc.
0.0358
-5.79%
 
ZOM Zomedica Corp.
0.1313
+0.92%
 
NUWE Nuwellis, Inc.
0.2964
-9.36%
 
HSCS Heart Test Laboratories, Inc.
0.0989
-1.00%
 
MOTS Motus GI Holdings, Inc.
0.0700
0.00%
 
DYNT Dynatronics Corporation
0.5392
+0.22%
 
INBS Intelligent Bio Solutions Inc.
2.7800
+4.51%
 
OPGN OpGen, Inc.
0.6130
+2.51%
 
TIVC Tivic Health Systems, Inc.
1.1293
-0.94%
 
NAOV NanoVibronix, Inc.
0.7699
+3.20%